Illustration: A. Canamucio In recent commentaries in Nature,1 the New York Times Magazine,2 and the American Scholar,3 the scientific article has come under attack because it has allegedly degenerated into a thick "molasses of jargon and academic code."2 Furthermore, according to scientist Peter Medawar in a 1964 Saturday Review essay,4 because the structure of the scientific article seriously misrepresents the way science happens, authors of scientific articles are also mendacious, perpetrators
| Illustration: A. Canamucio |
 |
It cannot account for the fact that science is a successful enterprise, an enterprise whose success depends crucially on the efficacy and honesty of its communicative practices. Contemporary scientists convey their discoveries in the writing conventions of their time, just as Newton, Franklin, Darwin, Mendeleev, Curie, and Einstein did in their time. While Nature, ...
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
